MCRB
Seres Therapeutics, Inc. (MCRB)
NASDAQ · Healthcare
Seres Therapeutics, Inc. annual/quarterly long term debt history from 2019 to 2023. Long term debt refers to financial obligations that are due more than one year in the future.
- Seres Therapeutics, Inc. long term debt for the quarter ending December 31, 2023 were 110.0M, a 120.00% increase year-over-year.
- Seres Therapeutics, Inc. long term debt for 2023 were 110.0M, a 120.00% increase from 2022.
- Seres Therapeutics, Inc. long term debt for 2022 were 50.0M, a 107.89% increase from 2021.
- Seres Therapeutics, Inc. long term debt for 2021 were 24.1M, a 3.80% decrease from 2020.
- Seres Therapeutics, Inc. long term debt for 2020 were 25.0M.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Seres Therapeutics, Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2023 | $110 |
| 2022 | $50 |
| 2021 | $24 |
| 2020 | $25 |
| 2019 | $25 |
| Seres Therapeutics, Inc. Quarterly Long Term Debt (Millions of US $) | |
|---|---|
| 2023-12-31 | $110 |
| 2022-12-31 | $50 |
| 2021-12-31 | $24 |
| 2020-12-31 | $25 |
| 2019-12-31 | $25 |
Seres Therapeutics, Inc. Long Term Debt — FAQ
Seres Therapeutics, Inc. (MCRB) long term debt over the last 11 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see MCRB's long term debt history?
The chart and table above show Seres Therapeutics, Inc.'s long term debt by year and by quarter, including the growth rate.